Miracle Mile Advisors LLC Acquires Shares of 2,460 SPDR S&P Biotech (XBI)

Miracle Mile Advisors LLC acquired a new stake in SPDR S&P Biotech (NYSEARCA:XBI) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 2,460 shares of the exchange traded fund’s stock, valued at approximately $209,000.

Several other hedge funds also recently modified their holdings of the stock. Crescent Grove Advisors LLC raised its stake in shares of SPDR S&P Biotech by 28.6% in the 4th quarter. Crescent Grove Advisors LLC now owns 118,270 shares of the exchange traded fund’s stock valued at $10,038,000 after acquiring an additional 26,290 shares in the last quarter. Bruderman Asset Management LLC increased its position in SPDR S&P Biotech by 11.6% in the 4th quarter. Bruderman Asset Management LLC now owns 40,002 shares of the exchange traded fund’s stock worth $3,395,000 after buying an additional 4,167 shares during the period. Calton & Associates Inc. bought a new position in SPDR S&P Biotech in the 4th quarter worth approximately $158,000. Claraphi Advisory Network LLC bought a new position in SPDR S&P Biotech in the 4th quarter worth approximately $423,000. Finally, SeaCrest Wealth Management LLC bought a new position in SPDR S&P Biotech in the 4th quarter worth approximately $146,000.

SPDR S&P Biotech (NYSEARCA XBI) opened at $87.02 on Friday. The company has a market capitalization of $4,470.00 and a P/E ratio of 4.77. SPDR S&P Biotech has a 1 year low of $65.85 and a 1 year high of $97.98.

TRADEMARK VIOLATION NOTICE: “Miracle Mile Advisors LLC Acquires Shares of 2,460 SPDR S&P Biotech (XBI)” was reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this article on another site, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this article can be accessed at https://www.com-unik.info/2018/02/10/miracle-mile-advisors-llc-acquires-shares-of-2460-spdr-sp-biotech-xbi.html.

SPDR S&P Biotech Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit